Lupus · 2006 · 18 citations · 21 references
MedicineNephrologyPharmacotherapyClinical PharmacologyPediatric NephrologyRenal PharmacotherapyRenal DiseaseRenal Function TestsRenal ImpairmentRenal PharmacologySystemic Lupus ErythematosusChildhood-onset Systemic Lupus ErythematosusLupus Nephritis RecurrenceLupus Nephritis TherapyPediatric Creatinine ClearancePrednisone UseProteinuria ReductionSerum Creatinine Assessment
We performed a prospective study to evaluate the efficacy and safety of low-dose cyclosporine A (CSA) treatment in paediatric lupus nephritis refractory to conventional therapy. Seven children with biopsy-proven Class III-IV lupus nephritis were treated with CSA (2-4 mg/kg/day) combined with low-dose prednisone for one year. All patients had failed to achieve sustained proteinuria remission with corticosteroids and cytotoxic drugs. Proteinuria decreased from median value of 2.5 g/24 hours (range, 1.2-4.9) to 0.14 g/24 hours (range, 0.0-0.84) after treatment (P = 0.018). Median values of creatinine clearance and serum creatinine did not change significantly. Median systemic lupus erythematosus disease activity index score decreased from 12 (range, 6-16) to 4 (range, 0-8) at end of treatment (P = 0.027). However, two patients experienced flares of extrarrenal manifestations and complement levels did not improve. Moreover, most patients relapsed with proteinuria within a few months of stopping CSA therapy. Side effects were not significant. In conclusion, low-dose of CSA combined with steroids appears to be useful to reduce proteinuria in paediatric proliferative lupus nephritis refractory to steroids and cytotoxic drugs; however, relapses are common after CSA discontinuation. Further studies are needed to define the precise role of CSA in paediatric lupus nephritis.
21
The 1982 revised criteria for the classification of systemic lupus erythematosus
Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism · 1982 · 14.6K citations
Derivation of the sledai. A disease activity index for lupus patients
Claire Bombardier, Dafna D. Gladman, Murray B. Urowitz et al. · Arthritis & Rheumatism · 1992 · 4.6K citations
Howard A. Austin, John H. Klippel, James E. Balow et al. · New England Journal of Medicine · 1986 · 1.2K citations
Long-term follow-up of patients with lupus nephritis
Gerald B. Appel, David J. Cohen, Conrad L. Pirani et al. · The American Journal of Medicine · 1987 · 284 citations
Medicine, Nephrology, Pathology +17